Global ePRO, E-Patient Diaries and eCOA Market Research Report 2023: Trends in Clinical Trials to Influence Market Demand - Forecast to 2030

Rhea-AI Summary

The global market for ePRO, E-Patient Diaries, and eCOA is projected to grow from US$1.6 billion in 2022 to US$4.8 billion by 2030, reflecting a CAGR of 15%. Growth in eClinical Outcome Assessments (eCOAs) is anticipated at 15.3% CAGR, reaching US$1.5 billion. The U.S. market is valued at US$561.4 million, while China is expected to achieve US$620.8 million at a CAGR of 17.9%. The 2023 outlook indicates challenges from supply chain disruptions, financial market volatility, and regulatory pressures, but opportunities exist for adaptable businesses.

Positive

• Projected market growth from US$1.6 billion in 2022 to US$4.8 billion by 2030.
• eCOAs expected to grow at a CAGR of 15.3%, reaching US$1.5 billion.
• U.S. market valued at US$561.4 million; China forecasted at US$620.8 million with a CAGR of 17.9%.

Negative

• Potential supply chain pain and disruptions due to COVID-19 and geopolitical tensions.
• Volatile financial markets and increasing trade tensions may impact growth.

DUBLIN, Feb. 28, 2023 /PRNewswire/ -- The "ePRO, E-Patient Diaries and eCOA: Global Strategic Business Report" report has been added to  ResearchAndMarkets.com's offering.

Global ePRO, E-Patient Diaries and eCOA Market to Reach $4.8 Billion by 2030

In the changed post COVID-19 business landscape, the global market for ePRO, E-Patient Diaries and eCOA estimated at US$1.6 Billion in the year 2022, is projected to reach a revised size of US$4.8 Billion by 2030, growing at a CAGR of 15% over the analysis period 2022-2030.

eClinical Outcome Assessments (eCOAs), one of the segments analyzed in the report, is projected to record a 15.3% CAGR and reach US$1.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Epatient Reported Outcomes (epros) segment is readjusted to a revised 16.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $561.4 Million, While China is Forecast to Grow at 17.9% CAGR

The ePRO, E-Patient Diaries and eCOA market in the U.S. is estimated at US$561.4 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$620.8 Million by the year 2030 trailing a CAGR of 17.9% over the analysis period 2022 to 2030.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.4% and 14.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 13.3% CAGR.

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year.

Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced.

Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

What`s New for 2023?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year

Key Metrics

Report Attribute	Details
No. of Pages	360
Forecast Period	2022 - 2030
Estimated Market Value (USD) in 2022	$1.6 Billion
Forecasted Market Value (USD) by 2030	$4.8 Billion
Compound Annual Growth Rate	14.7 %
Regions Covered	Global

Key Topics Covered:

MARKET OVERVIEW

• Impact of COVID-19 Pandemic and Looming Global Recession
• Year 2021 in Review and Near-term Outlook
• Pandemic Jolt Brings Strategic & Lasting Changes to Healthcare Sector
• COVID-19 Expedites Healthcare Ecosystem's Evolution for Better Care & Cost Savings
• The Adoption of Telemedicine Services Accelerates Amidst the Pandemic
• Telemedicine Leads Digital Health Investments Driven by COVID-19
• Pandemic Impact on eCOA, ePRO Market
• COVID-19 Outbreak Compels Clinical Trials Industry to Move Towards ePRO
• eCOA Solutions Help Address Hurdles Due to COVID-19 Pandemic
• eCOA Playing a Part in Development of COVID-19 Vaccine
• An Introduction to ePRO, E-Patient Diaries and eCOA
• Global Market Prospects & Outlook
• eCOA: The Largest Category
• Competition
• Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
• Recent Market Activity

MARKET TRENDS & DRIVERS

• Digitalization of Healthcare Services and Rising Importance of Electronic Data Capture Technologies to Fuel Market Growth
• Growing Demand for Clinical Trials Drives Need for ePRO, ePatient Diaries, and eCOA Solutions
• Industry-Funded, Interventional Clinical Trial Study Starts for the Period 2015-2022E
• Breakdown of Trial Starts by Therapeutic Area (2021)
• COVID-19 Pandemic Triggers Technology Adoption in Clinical Trials
• Global Venture Funding (in $ Million) in Digital Health Solutions Targeting Clinical Trials for 2015-2020
• Trends in Clinical Trials to Influence Market Demand
• Clinical Trials Increasingly Embraced Technology Amid COVID-19 Pandemic
• Shift Towards Decentralized/Virtual Clinical Trials to Boost Market Prospects
• Global Virtual Clinical Trials Market Size (in US$ Billion) for the Years 2020, 2022, 2024 and 2026
• Decentralized Clinical Trials Driving Greater Demand for Patient-Centric Drug Development
• Role of eCOA & ePRO in Enhancing Data Accuracy of Decentralized Clinical Trials
• Growing Volumes of Data Generation in Decentralized Trials: A Challenge
• Adoption of Digital Technologies in Contract Research Organizations Bodes Well for the Market
• COVID-19 and Implications for Drug Development Regulations & Processes
• Advances in ePRO Technologies Promise Better Clinical Decision Making in Healthcare Systems
• Rise in Telemedicine Services Present Market Opportunities
• Growing Adoption of Mobile Technologies and BYOD Trend in Healthcare Industry Boosts Market Prospects
• Electronic Patient Record (ePRO) Solutions Emerge as Ideal Replacements for Paper-Based PRO systems
• Major Benefits of ePRO over Paper Form in Clinical Trials
• Delivering Better Data: A Key Benefit of ePRO
• Factors Ensuring Success ePRO Implementations
• ePatient-Reported Outcomes (PROs) Gain Importance in Oncology Studies
• Key Technology Trends Impacting the ePRO in Clinical Trials
• Data Integrity, Security & Privacy: Key Priorities for ePRO Solutions
• Integrating AI Into ePRO Improves the Efficiency of ePRO Data Collection and Assessment
• Electronic Clinical Outcome Assessment Solution (eCOA) Market: Poised for Growth
• Global e-COA Market by Delivery Mode (in %) for 2022E
• eCOA Usage by Clinical Trial Phase (in %) for 2021
• Technological Trends Transforming eCOA Solutions Market
• Future Trends in eCOA Market: A Review
• eCOA Proves Beneficial in Addressing Clinical Trial Challenges During COVID-19 Pandemic
• UAT, Challenges and Embedded UAT for eCOAs
• Benefits of BYOD for eCOAs
• E-Patient Diaries: Significant Advantages over Paper Diaries to Drive Market
• Major Benefits of ePatient Diary
• Increase in Healthcare Spending to Propel Demand
• Increasing Burden of Chronic Diseases and Focus on Drug Development, Therapies and Vaccines Boosts Market
• Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
• Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
• Aging World Population & COVID-19 Induced Re-Focus on Aging-In-Place to Drive Market Growth

FOCUS ON SELECT PLAYERS (Total 75 Featured)

• Anju Software, Inc.
• ArisGlobal LLC
• Castor EDC
• Clario
• Climedo Health GmbH
• ClinCapture
• Dassault Systemes SE
• eClinical Solutions LLC
• ICON plc
• IQVIA Holdings, Inc.
• Kayentis, SAS
• Medidata Solutions Inc.
• Mednet
• Signant Health
• TransPerfect

For more information about this report visit https://www.researchandmarkets.com/r/8xnttd-e-patient?w=5

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/global-epro-e-patient-diaries-and-ecoa-market-research-report-2023-trends-in-clinical-trials-to-influence-market-demand---forecast-to-2030-301758286.html

SOURCE Research and Markets

FAQ

What is the projected market size for ePRO, E-Patient Diaries, and eCOA by 2030?

The market is projected to reach US$4.8 billion by 2030.

What factors are driving the growth of the ePRO market?

The growth is driven by the digitalization of healthcare and increasing demand for clinical trials.

How is the market for eClinical Outcome Assessments (eCOAs) expected to perform?

eCOAs are expected to grow at a CAGR of 15.3%, reaching US$1.5 billion by 2030.

What challenges does the ePRO market face in 2023?

Challenges include potential supply chain disruptions, financial market volatility, and regulatory pressures.

What was the value of the U.S. ePRO market in 2022?

The U.S. ePRO market was valued at US$561.4 million in 2022.